Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MTM1 encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. Additionally we are shipping MTM1 Kits (4) and MTM1 Proteins (4) and many more products for this protein.
Showing 10 out of 76 products:
Human Polyclonal MTM1 Primary Antibody for IHC (p), WB - ABIN1882103
Herman, Kopacz, Zhao, Mills, Metzenberg, Das: Characterization of mutations in fifty North American patients with X-linked myotubular myopathy. in Human mutation 2002
Show all 6 references for ABIN1882103
Human Polyclonal MTM1 Primary Antibody for EIA, WB - ABIN359029
Biancalana, Caron, Gallati, Baas, Kress, Novelli, DApice, Lagier-Tourenne, Buj-Bello, Romero, Mandel: Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. in Human genetics 2003
Show all 3 references for ABIN359029
Human Monoclonal MTM1 Primary Antibody for IHC (p), RNAi - ABIN561867
Hedberg, Lindberg, Máthé, Moslemi, Oldfors: Myopathy in a woman and her daughter associated with a novel splice site MTM1 mutation. in Neuromuscular disorders : NMD 2012
Human Polyclonal MTM1 Primary Antibody for ELISA, WB - ABIN268752
Laporte, Hu, Kretz, Mandel, Kioschis, Coy, Klauck, Poustka, Dahl: A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. in Nature genetics 1996
Results confirm that the severe neonatal onset of myopathy in male infants is sufficient to address the direct molecular testing toward the MTM1 gene and, above all, suggest that the number of undiagnosed symptomatic female carriers is probably underestimated
This study demonistrated that MTM1 mutation releated to Centronuclear myopathy.
mutations in SPEG (show SPEG Antibodies) cause a centronuclear myopathy phenotype as a result of its interaction with MTM1.
Mutations in specific myotubularins such as MTM1 result in myotubular myopathy and Charcot-Marie-Tooth peripheral neuropathy. (Review)
Large duplications in MTM1 may account for a number of Centronuclear myopathy cases that have remained genetically unresolved.
Analysis of human XLMTM patient myotubes showed that mutations that disrupt the interaction between myotubularin and MTMR12 (show MTMR12 Antibodies) proteins result in reduction of both myotubularin and MTMR12 (show MTMR12 Antibodies)
data explain the basis for phenotypic variability among human patients with MTM1 p.R69C mutations and establish the Mtm1 p.R69C mouse as a valuable model for the disease, as its less severe phenotype will expand the scope of testable preclinical therapies
The patients of Myopathy had a novel heterozygous splice site mutation in the myotubularin gene, MTM1 (c.867+1G>T). Analysis of MTM1 cDNA revealed that the mutation resulted in aberrant splicing with variable exon skipping.
A nonsense mutation Arg486STOP was identified in exon 7 of the MTM1 gene.
Myotubularin regulates Akt (show AKT1 Antibodies)-dependent survival signaling via phosphatidylinositol 3-phosphate.
Differential muscle hypertrophy is associated with satellite cell numbers and Akt (show AKT1 Antibodies) pathway activation following activin type IIB receptor (show ACVR2B Antibodies) inhibition in Mtm1
MTM1 interacts with BIN1 (show BIN1 Antibodies) in skeletal muscle.
Data show that the IGF1R (show IGF1R Antibodies)/Akt (show AKT1 Antibodies) pathway is affected in phosphoinositide phosphatase myotubularin (MTM1)-deficient muscles.
Deletion of the Mtm1 gene in a mature muscle reproduces the pathological hallmarks of myotubular myopathy.
study reveal a direct function of MTM1 enzymatic activity in SR remodeling and a key role for PtdIns3P in promoting SR membrane curvature in skeletal muscle.
aberrant mTORC1 signaling and impaired autophagy are consequences of the loss of Mtm1
Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
These studies demonstrate specific abnormalities in myogenic cell number and behavior that may relate to the progression of disease in myotubularin deficiency.
Inhibition of activin receptor type IIB (show ACVR2B Antibodies) increases strength and lifespan in myotubularin-deficient mice.
This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy.
, X-linked myotubular myopathy gene 1